Photo from Harold Burstein/X
Apr 30, 2024, 12:22
Harold Burstein: ER-low tumors will require chemotherapy and endocrine therapy
Harold Burstein, Breast Cancer Specialist and Professor at Dana Farber Cancer Institute, shared a post by Annals of Surgical Oncology on X/Twitter, adding:
”Key clinical takeaway is that in contemporary breast cancer pathology, most ER-low (< 10%) tumors will require chemotherapy and endocrine therapy.”
Quoting Annals of Surgical Oncology’s post:
”April Issue: Defining the Biology of Estrogen Receptor-Low-Positive.”
Source: Harold Burstein/X and AnnalsSurgOncology/X
May 16, 2024, 16:08